53
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Albuterol Delivered by Metered-Dose Inhaler (MDI), MDI with Spacer, and RotahalerTM Device-A Comparison of Efficacy and Safety

, , , , , & show all
Pages 373-379 | Published online: 02 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Gordon Raphael, Herminia Taveras, Harald Iverson, Christopher O’Brien & David Miller. (2016) Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma. Journal of Asthma 53:2, pages 187-193.
Read now

Articles from other publishers (5)

Lan‐Hong Ma, Li Jia & Ling Bai. (2023) Safety outcomes of salbutamol: A systematic review and meta‐analysis. The Clinical Respiratory Journal.
Crossref
Rakesh KumarDr.Dr.. (2021) A COMPARATIVE STUDY OF METERED DOSE INHALER WITH SPACER AND DRY POWDER INHALER FOR DELIVERY OF SALBUTAMOL IN ACUTE EXACERBATIONS OF BRONCHIAL ASTHMA. PARIPEX INDIAN JOURNAL OF RESEARCH, pages 25-26.
Crossref
Federico Lavorini, Pietro Geri, Martina Luperini, Nazzarena M. Maluccio, Laura Mariani, Cecilia Marmai, Massimo Pistolesi & Giovanni A. Fontana. (2004) Clinical and functional responses to salbutamol inhaled via different devices in asthmatic patients with induced bronchoconstriction. British Journal of Clinical Pharmacology 58:5, pages 512-520.
Crossref
Felix S. F. Ram. (2012) Clinical Efficacy of Inhaler Devices Containing β2-Agonist Bronchodilators in the Treatment of Asthma. American Journal of Respiratory Medicine 2:4, pages 349-365.
Crossref
Felix SF Ram, David DM Brocklebank, John White, John J Wright & Paul Jones. (2002) Pressurised metered dose inhalers versus all other hand-held inhaler devices to deliver beta-2 agonist bronchodilators for non-acute asthma. Cochrane Database of Systematic Reviews 2010:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.